| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 04/06/2000 | WO2000018759A1 Phenylalanine derivatives as alpha 4 integrin inhibitors |
| 04/06/2000 | WO2000018740A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 04/06/2000 | WO2000018739A1 Method for preparing 4-hydroxyquinolines and/or tautomeric forms |
| 04/06/2000 | WO2000018738A1 Benzamide derivatives and their use as cytokine inhibitors |
| 04/06/2000 | WO2000018735A1 2-substituted heterocyclic sulfonamides |
| 04/06/2000 | WO2000018733A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals |
| 04/06/2000 | WO2000018409A1 Use of certain drugs for treating nerve root injury |
| 04/06/2000 | WO1999037294A3 Mitochondria protecting agents for treating mitochondria associated diseases |
| 04/06/2000 | CA2714449A1 Use of certain drugs for treating nerve root injury |
| 04/06/2000 | CA2340454A1 Benzamide derivatives and their use as cytokine derivatives |
| 04/06/2000 | CA2338442A1 Phenylalanine derivatives as alpha 4 integrin inhibitors |
| 04/05/2000 | EP0990648A1 4-quinolinol derivatives and agrohorticultural bactericides containing the same as active ingredient |
| 04/05/2000 | EP0990647A1 Process for producing quinolone derivatives |
| 04/05/2000 | EP0990439A1 Bisaryl compounds and cancer remedies containing the same |
| 04/05/2000 | EP0989857A1 Novel therapeutic agents that modulate enzymatic processes |
| 04/05/2000 | EP0716661B1 Pseudo- and non-peptide bradykinin receptor antagonists |
| 04/05/2000 | CN1249825A Photosensitive quinolone compounds and process of preparation |
| 04/05/2000 | CN1249753A Farnesyl transferase inhibiting 1,8-annelated quinolinone derivs. substd. with N- or C-linked imidazoles |
| 04/05/2000 | CN1051087C Process for preparation of diisopinocampheylchloroborane |
| 04/04/2000 | US6046212 Antiallergic agents |
| 04/04/2000 | US6046211 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 03/30/2000 | WO2000017166A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 03/30/2000 | WO2000017165A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 03/30/2000 | WO2000017164A1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 03/30/2000 | WO2000016766A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent |
| 03/30/2000 | CA2344556A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines |
| 03/30/2000 | CA2342607A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent |
| 03/29/2000 | EP0988280A1 Hydroxamic acid compounds having anticancer and anti-parasitic properties |
| 03/29/2000 | EP0988045A1 Peptide nucleic acid monomers and oligomers |
| 03/29/2000 | EP0987997A1 N-methyl-d-aspartate (nmda) receptor blockers for the prevention of atherosclerosis |
| 03/29/2000 | CN1248968A Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-alpha binding to its CCRI receptor |
| 03/28/2000 | US6043247 Modulators of molecules with phosphotyrosine recognition units |
| 03/28/2000 | CA2160270C 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
| 03/23/2000 | WO2000015617A1 2-aminoethyl-quinoline derivatives, preparation and therapeutic use |
| 03/23/2000 | WO2000015612A1 Aza-bicycles which modulate the inhibition of cell adhesion |
| 03/23/2000 | WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS |
| 03/23/2000 | CA2341677A1 Aza-bicycles which modulate the inhibition of cell adhesion |
| 03/22/2000 | EP0987263A2 Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors |
| 03/22/2000 | EP0987251A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as CETP inhibitors |
| 03/22/2000 | EP0987248A1 Amide derivatives and their therapeutic use |
| 03/22/2000 | EP0986540A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 03/22/2000 | EP0820607B1 Photographic system |
| 03/22/2000 | EP0775114B1 Process for making antimicrobial compounds |
| 03/22/2000 | CN1247865A Prepn. of quinolone and 1,8-diaza-naphthalenone carboxylic acid |
| 03/21/2000 | US6040463 Sordarin derivatives |
| 03/21/2000 | US6040448 Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl) piperazines, dopamine receptor subtype specific ligands |
| 03/17/2000 | CA2282112A1 Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines |
| 03/16/2000 | WO2000014815A1 Electro-luminescent arrangements with thiophene carboxylate metal complexes |
| 03/16/2000 | WO2000014070A1 Antimalarial compounds |
| 03/16/2000 | WO2000014069A1 Cyclohexenonquinolinoyl-derivatives as herbicidal agents |
| 03/16/2000 | WO2000013681A2 4-quinolinemethanol derivatives as purine receptor antagonists (i) |
| 03/16/2000 | WO2000008014A8 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect |
| 03/16/2000 | WO1999064047A9 Novel antiviral compounds |
| 03/16/2000 | WO1999063929A9 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/16/2000 | CA2343144A1 Cyclohexenonequinolinoyl-derivatives as herbicidal agents |
| 03/15/2000 | EP0984967A1 Naphthyridine derivatives and their analogues inhibiting cytomegalovirus |
| 03/15/2000 | EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 03/15/2000 | EP0984941A2 Quinoline and acridine derivatives as antiarrhythmic agents |
| 03/14/2000 | US6037350 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quionlinone derivatives |
| 03/14/2000 | CA2184919C New piperazine derivatives and methods for the preparation thereof and compositions containing the same |
| 03/09/2000 | WO2000012500A2 2-aryl-4-(1-[4-heteroaryl]piperazin-1-yl) methylimidazoles: dopamine d4 receptor subtype ligands |
| 03/09/2000 | WO2000012499A1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 03/09/2000 | WO2000012479A1 2-oxo-2h-quinoline derivatives |
| 03/09/2000 | WO2000012478A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 03/09/2000 | WO2000012077A1 Potassium channel inhibitors and method |
| 03/09/2000 | WO2000012076A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 03/09/2000 | DE19839947A1 Elektrolumineszierende Anordnungen mit Thiophencarboxylat-Metallkomplexen Electroluminescent arrangements with thiophene carboxylate-metal complexes |
| 03/09/2000 | CA2342230A1 2-oxo-2h-quinoline derivatives |
| 03/09/2000 | CA2339189A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 03/08/2000 | EP0984010A1 Use in hair dyes of quinolin-5,8-diones or quinoxalin-5,8-diones condensed with substituted pyrroles, anilines or indoles |
| 03/08/2000 | EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 03/08/2000 | EP0983262A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists |
| 03/08/2000 | EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds |
| 03/08/2000 | EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 03/08/2000 | EP0983243A1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain |
| 03/08/2000 | EP0983228A1 Protease inhibitors |
| 03/08/2000 | CN1050127C Benocycloheptenes and benzoxepines preparing process thereof and pharmaceutical compositions containing them |
| 03/08/2000 | CN1050126C Tri-substituted imidazoles compound, process for preparing it and use and pharmaceutical compositions containing them |
| 03/07/2000 | US6034256 Substituted benzopyran derivatives for the treatment of inflammation |
| 03/07/2000 | US6034244 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity |
| 03/07/2000 | US6034241 Alkylation; heating |
| 03/07/2000 | US6034098 Inhibitors of microsomal triglyceride transfer protein and method |
| 03/07/2000 | US6034086 Viricides; aids therapy |
| 03/02/2000 | WO2000010993A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
| 03/02/2000 | WO2000010570A1 Aqueous liquid preparations |
| 03/02/2000 | WO1999064054A9 Multibinding inhibitors of topoisomerase |
| 03/02/2000 | WO1999063937A3 Multivalent macrolide antibiotics |
| 03/02/2000 | DE19839499A1 2-Oxo-2H-chinolinderivate 2-oxo-2H-quinoline |
| 03/01/2000 | EP0982300A2 Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications |
| 03/01/2000 | EP0981518A1 Substituted heterocyclic nitrogens, methods for producing same and their use as pest control agent |
| 03/01/2000 | CN1246116A Sulphonamide derivatives, process for their preparation and their use as medicaments |
| 03/01/2000 | CN1246112A Improved process for preparation of halo-4-phenoxyquinolines |
| 03/01/2000 | CN1049891C Dicyclomine compound and preparing method, and drug composition containing said compound |
| 03/01/2000 | CA2281177A1 Use in hair dye of condensates of quinoline-5,8-diones or quinoxaline-5,8-diones and substitute indoles, pyrroles or anilines |
| 02/29/2000 | US6031105 Substituted pyridines |
| 02/29/2000 | US6031102 Optically active pyridonecarboxylic acid derivatives |
| 02/29/2000 | US6030983 Lavendamycin analogs, quinoline-5,8-diones and methods of using them |
| 02/29/2000 | US6030964 Binds to retinoic acid receptors and useful for treating psoriasis, autoimmune diseases, tumors, rheumatoid arthritis and for inducing immunosuppression in organ transplantation |
| 02/29/2000 | US6030846 Homogeneous assays using avidin-binding azo reagents |
| 02/29/2000 | US6030546 Ferroelectric phase; low viscosity;, thermosensitivity over a broad and exhibits a large tilt angle and a high-speed response property;chemical intermediates for pesticides, drugs and liquid crystals; boriding and hydrolysis |